Is BioAge Labs Inc. (BIOA) a Buy, Sell, or Hold?
NASDAQ : BIOA
BioAge Labs Inc.
$23.24 USD
$1.08 (4.87%)
- Volume
- 163.72K
- Average Volume
- 524.61K
- Market Capitalization
- $874.98M
- P/E Ratio
- -9.68
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $25.96
- Year Low
- $4.11
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $24.76
Insider Activity Summary (Last 12 Months)
Insiders Buying
36
Insiders Selling
36
Amount of Insider Selling
$659.81K
BIOA Insider Buying/Selling by Quarter
BIOA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 4.38 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 4.38 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 4.38 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 4.3 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 4.3 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 4.3 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 8.39 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 4.38 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 8.39 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 10.85 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 8.39 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 10.85 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 4.3 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | M-Exempt | 10.85 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 8.39 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | M-Exempt | 10.85 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-30 | S-Sale | 25.1868 | 2026-07-01 |
| Barton Shane | officer: Principal Accounting Officer | 2026-06-29 | S-Sale | 25.2084 | 2026-07-01 |
| Pande Vijay Satyanand | director | 2026-06-10 | A-Award | 15.48 | 2026-06-12 |
| Hemrajani Rekha | director | 2026-06-10 | A-Award | 15.48 | 2026-06-12 |
| HEALY JAMES | director | 2026-06-10 | A-Award | 15.48 | 2026-06-12 |
| ENRIGHT PATRICK G | director | 2026-06-10 | A-Award | 15.48 | 2026-06-12 |
| Davidson Michael H. | director | 2026-06-10 | A-Award | 15.48 | 2026-06-12 |
| GARNIER JEAN PIERRE | director | 2026-06-10 | A-Award | 15.48 | 2026-06-12 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-04-23 | M-Exempt | 4.38 | 2026-04-24 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-04-23 | M-Exempt | 4.38 | 2026-04-24 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 6.57 | 2026-04-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 4.11 | 2026-04-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-04-01 | S-Sale | 17.81 | 2026-04-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 4.11 | 2026-04-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-04-01 | M-Exempt | 6.57 | 2026-04-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 6.57 | 2026-03-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 4.11 | 2026-03-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 4.11 | 2026-03-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-03-02 | M-Exempt | 6.57 | 2026-03-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-03-02 | S-Sale | 20.3 | 2026-03-03 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-03-01 | M-Exempt | 4.38 | 2026-03-03 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-03-01 | M-Exempt | 4.38 | 2026-03-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-02-17 | A-Award | 19.63 | 2026-02-19 |
| Morgen Eric | director, officer: Chief Operating Officer | 2026-02-17 | A-Award | 19.63 | 2026-02-19 |
| Morgen Eric | director, officer: Chief Operating Officer | 2026-02-17 | A-Award | 19.63 | 2026-02-19 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-02-17 | A-Award | 19.63 | 2026-02-19 |
| Fortney Kristen | director, officer: Chief Executive Officer | 2026-02-17 | A-Award | 19.63 | 2026-02-19 |
| Barton Shane | officer: Principal Accounting Officer | 2026-02-17 | A-Award | 19.63 | 2026-02-19 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-02-02 | M-Exempt | 4.11 | 2026-02-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-02-02 | M-Exempt | 6.57 | 2026-02-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-02-02 | M-Exempt | 4.11 | 2026-02-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-02-02 | M-Exempt | 6.57 | 2026-02-03 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-02-02 | S-Sale | 18.75 | 2026-02-03 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-02-01 | M-Exempt | 4.38 | 2026-02-03 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-02-01 | M-Exempt | 4.38 | 2026-02-03 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-16 | M-Exempt | 4.38 | 2026-01-21 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-16 | M-Exempt | 4.38 | 2026-01-21 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-13 | M-Exempt | 8.39 | 2026-01-15 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-13 | M-Exempt | 8.39 | 2026-01-15 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-13 | S-Sale | 18.4278 | 2026-01-15 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-13 | S-Sale | 19.4526 | 2026-01-15 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-13 | S-Sale | 20.5392 | 2026-01-15 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2026-01-13 | S-Sale | 21.0808 | 2026-01-15 |
| Fortney Kristen | director, officer: Chief Executive Officer | 2026-01-13 | S-Sale | 18.1163 | 2026-01-15 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-01-02 | M-Exempt | 4.11 | 2026-01-06 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-01-02 | M-Exempt | 6.57 | 2026-01-06 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-01-02 | M-Exempt | 6.57 | 2026-01-06 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-01-02 | M-Exempt | 4.11 | 2026-01-06 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2026-01-02 | S-Sale | 12.8468 | 2026-01-06 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-12-09 | M-Exempt | 6.57 | 2025-12-11 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-12-09 | M-Exempt | 6.57 | 2025-12-11 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-12-09 | S-Sale | 12 | 2025-12-11 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-12-04 | M-Exempt | 4.11 | 2025-12-05 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-12-04 | M-Exempt | 4.11 | 2025-12-05 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-12-04 | S-Sale | 10.1878 | 2025-12-05 |
| Pande Vijay Satyanand | director | 2025-08-07 | A-Award | 4.32 | 2025-08-11 |
| Hemrajani Rekha | director | 2025-06-05 | A-Award | 4.44 | 2025-06-09 |
| HEALY JAMES | director | 2025-06-05 | A-Award | 4.44 | 2025-06-09 |
| ENRIGHT PATRICK G | director | 2025-06-05 | A-Award | 4.44 | 2025-06-09 |
| Davidson Michael H. | director | 2025-06-05 | A-Award | 4.44 | 2025-06-09 |
| GARNIER JEAN PIERRE | director | 2025-06-05 | A-Award | 4.44 | 2025-06-09 |
| Hemrajani Rekha | director | 2024-09-27 | P-Purchase | 18 | 2025-03-10 |
| Barton Shane | officer: Principal Accounting Officer | 2024-09-27 | P-Purchase | 18 | 2025-03-10 |
| Morgen Eric | director, officer: Chief Operating Officer | 2025-02-18 | A-Award | 4.38 | 2025-02-25 |
| RUBIN PAUL D | officer: Chief Medical Officer | 2025-02-18 | A-Award | 4.38 | 2025-02-20 |
| Morgen Eric | director, officer: Chief Operating Officer | 2025-02-18 | A-Award | 4.38 | 2025-02-20 |
| GOLDSTEIN DOV A MD | officer: Chief Financial Officer | 2025-02-18 | A-Award | 4.38 | 2025-02-20 |
| Fortney Kristen | director, officer: Chief Executive Officer | 2025-02-18 | A-Award | 4.38 | 2025-02-20 |
| Barton Shane | officer: Principal Accounting Officer | 2025-02-18 | A-Award | 4.38 | 2025-02-20 |
| Barton Shane | officer: Principal Accounting Officer | 2024-12-18 | A-Award | 4.3 | 2024-12-20 |
| Eno Richard P | director, officer: Chief Executive Officer | 2018-04-02 | A-Award | 0.04 | 2018-04-03 |
| Eno Richard P | director, officer: Chief Executive Officer | 2017-10-02 | A-Award | 0.48 | 2017-10-05 |
| Eno Richard P | director, officer: Chief Executive Officer | 2017-09-18 | 0 | 2017-09-28 | |
| Haller Heinz | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| Haller Heinz | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| BRINER KURT W | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| BRINER KURT W | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| Millis James | officer: Chief Technology Officer | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| Millis James | officer: Chief Technology Officer | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| RICHSTONE ELLEN B | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| RICHSTONE ELLEN B | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| Settino Mario | officer: Chief Financial Officer | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| Settino Mario | officer: Chief Financial Officer | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |
| LAND RAYMOND J | director | 2017-08-15 | P-Purchase | 0.75 | 2017-08-16 |